By Dr John Walter Frew

Journal articles

El-Hamdi NS; Villamaria EE; Goldfarb N; Van der Zee HH; Garg A; Frew J; Sabat R; Alavi A, 2026, 'Harmonizing Hidradenitis Suppurativa: an Updated Glossary of Lesions with Clinical Presentations', Current Dermatology Reports, 15, http://dx.doi.org/10.1007/s13671-026-00492-4

Abu Rached N; Sabat R; Frew JW; Bechara FG, 2026, 'Editorial: Metainflammation and metabolism in hidradenitis suppurativa', Frontiers in Immunology, 17, pp. 1967931, http://dx.doi.org/10.3389/fimmu.2026.1967931

Kumar M; Nakad J; Kok C; Frew J; Sholji T, 2026, 'Interventions to Improve Treatment Adherence in Psoriasis: A Systematic Review', Australasian Journal of Dermatology, 67, pp. e337 - e347, http://dx.doi.org/10.1111/ajd.70145

Grange R; Sholji T; Aghajani M; Kok C; Frew J, 2026, 'Pyoderma Gangrenosum: A Retrospective Cohort Study of Comorbidities and Therapies in Over 65,000 Patients in the TriNetX Database', JEADV Clinical Practice, 5, pp. 933 - 938, http://dx.doi.org/10.1002/jvc2.70346

Porter ML; Martorell A; Sayed CJ; Bechara FG; Lev-Tov H; Hsiao JL; Frew JW; Reguiaï Z; Gooderham MJ; Goldfarb N; van der Zee HH; del Marmol V; Marzano AV; Ehst BD; Ackerman LS; Hayama K; Tian C; Kelley J; Zhen H; Kirby JS; Brown K; Santos LL; Zouboulis CC, 2026, 'Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials', Nature Medicine, 32, pp. 3071 - 3081, http://dx.doi.org/10.1038/s41591-026-04534-z

Keith YH; Duchini E; Lin X; Kyaw W; Weninger FGP; Dhenni R; Telfser AJ; Grootveld AK; Barkauskas D; Fontaine-Titley A; Tikoo S; Jain R; Weninger W; Frew JW; Deenick EK; Brink R; Martin LK; Chtanova T; Goldstein LD; Scolyer RA; Long GV; Palendira U; Phan TG, 2026, 'CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skin', Journal of Experimental Medicine, 223, http://dx.doi.org/10.1084/jem.20252239

Marzano AV; Bechara FG; Shi VY; Martorell A; Hsiao JL; Van der Zee HH; Villani AP; Alavi A; Ingram JR; Sayed CJ; Tzellos T; Chandran NS; Ju Q; Kurokawa I; Frew JW; Gulliver WPF; Rivitti-Machado MC; Wortsman X; McGrath BM; Pintori G; Jordan V; Thomas N; Alarcon I; Zouboulis CC, 2026, 'Criteria for Hidradenitis Suppurativa Competence Centers', Dermatology and Therapy, 16, pp. 3445 - 3460, http://dx.doi.org/10.1007/s13555-026-01783-1

Frew JW; Bechara FG, 2026, 'Medical and Surgical Management of Hidradenitis Suppurativa', Journal of Clinical Medicine, 15, http://dx.doi.org/10.3390/jcm15135238

Stewart T; Farrell J; Cook D; Frew J, 2026, 'Predictors of Survival and Length of Stay in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Single-Center Retrospective Study of 111 Patients', Journal of Burn Care and Research, 47, pp. 1082 - 1088, http://dx.doi.org/10.1093/jbcr/irag037

Magnolo N; Soung J; Frew J; Costanzo A; Ruiz-Santiago H; Eyerich K; Llamas-Velasco M; Bukhalo M; Sivamani RK; Moore A; Wu T; Xie J; Patel M; Ashley D; Kaplan B; Stakias V; Espaillat R; Warren RB, 2026, 'Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial', Dermatology and Therapy, 16, pp. 3415 - 3429, http://dx.doi.org/10.1007/s13555-026-01779-x

Pham J; Sholji T; Aghajani M; Maye E; Burrell K; Kok C; Frew JW, 2026, 'Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease Severity', Australasian Journal of Dermatology, 67, pp. e154 - e161, http://dx.doi.org/10.1111/ajd.70085

Bouazzi D; Lophaven S; Hagan PG; Botvid S; Hove LS; Prens EP; Knecht-Gurwin K; Szepietowski JC; Anaba EL; Chehad AS; Zobiri S; Serradj A; Bhuiyan MSI; Noor T; Guillem P; Parvizi MM; Saki N; Alpsoy E; Vardar C; Kanni T; Giamarellos-Bourboulis EJ; Frew JW; Maharbi WHAA; van Huijstee JC; Aarts P; Dewi ST; Febriana SA; Indrastuti N; Suryawati N; Pangastuti M; Adji A; Akhyar G; Nopriyati ; Hazlianda CP; Reyes-Baraona F; Matas C; Saeed H; Moodley A; Binamer Y; Kamil MAA; Jocic I; Mijuskovic Z; Mallawaarachchi K; Gangani C; Tusheva I; Boshkovski VB; Hu D; Geng S; Medianfar CE; Saunte DML; Chandran NS; Van Der Zee HH; Zouboulis CC; Benhadou F; Villumsen B; Alavi A; Ibekwe PU; Hamzavi IH; Ingram JR; Naik HB; Garg A; Boer J; Christensen R; Jemec GBE, 2026, 'Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study', British Journal of Dermatology, 194, pp. 869 - 878, http://dx.doi.org/10.1093/bjd/ljag005

Wortsman X; Alfageme F; Dini V; García-Martínez FJ; Caposiena Caro RD; Frew J; Gonzalez C; Hamzavi IH; Kohli I; Krajewski PK; Kuyumllian M; Liu J; Mandava A; Nazzaro G; O'Brien E; Oranges T; Pelizzari M; Rezende J; Romani J; Sigrist R; Taleb E; Zattar L; Zavariz J; Martorell A, 2026, 'International consensus statement on the use of ultrasound in hidradenitis suppurativa', Journal of the European Academy of Dermatology and Venereology, 40, pp. 626 - 636, http://dx.doi.org/10.1111/jdv.20600

Stewart TJ; Farrell JA; Cook D; Frew JW, 2026, 'Prevalence and predictors of posttraumatic stress disorder in Stevens Johnson syndrome and toxic epidermal necrolysis', Journal of the European Academy of Dermatology and Venereology, 40, pp. e234 - e235, http://dx.doi.org/10.1111/jdv.20891

Martorell A; Ingram JR; Sayed CJ; Bechara FG; Porter ML; Tzellos T; Naik HB; Kirby B; van Straalen KR; Frew JW; Alarcon I; Jordan M V; Garg A, 2026, 'Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment', American Journal of Clinical Dermatology, 27, pp. 217 - 226, http://dx.doi.org/10.1007/s40257-026-01011-8

Punchihewa N; Nguyen JK; Armstrong JM; Vogrin S; Dolianitis C; Baker C; Marshman G; Frew J; Wu J; Lowe P; Foley P, 2026, 'Real-World Efficacy and Drug Survival of Adalimumab in Australian Patients With Psoriasis', Australasian Journal of Dermatology, 67, pp. e91 - e98, http://dx.doi.org/10.1111/ajd.70024

Aghajani M; Lu JT; Frew JW; Sebaratnam DF, 2026, 'The evolving genetic landscape of ILVEN: A comprehensive review', Journal of the European Academy of Dermatology and Venereology, 40, pp. 353 - 360, http://dx.doi.org/10.1111/jdv.70098

Aghajani M; Pham J; Sholji T; Burrell K; Kok C; Frew JW, 2026, 'Originator versus biosimilar adalimumab in hidradenitis suppurativa: A multicenter real-world analysis of clinical response, maintenance of response, and switching', Jaad International, 24, pp. 9 - 15, http://dx.doi.org/10.1016/j.jdin.2025.05.023

Islam R; Jones C; Stewart T; Kok C; Frew J; Elhindi J; Lee S; Bonilla GM, 2026, 'Ten Years of Scalp Keratinocyte Carcinomas (Basal Cell Carcinomas and Squamous Cell Carcinomas) Treated by Mohs Micrographic Surgery at a Large Australian Centre, a Descriptive Study', Australasian Journal of Dermatology, 67, pp. 18 - 23, http://dx.doi.org/10.1111/ajd.70000

Tseng H; Frew JW; Murrell DF, 2026, 'Viral infections as triggers in autoimmune blistering diseases: A systematic review of associations and mechanisms', Jaad International, 24, pp. 132 - 133, http://dx.doi.org/10.1016/j.jdin.2025.09.007

Garg A; Strunk A; Midgette B; Frasier K; Cohn E; Aarts P; Alavi A; Alhusayen R; Bechara BFG; Bettoli V; Brassard A; Brown DP; Chandran NS; Choon SE; Cohen SR; Daveluy S; Del Marmol V; Dellavalle RP; Emtestam L; Farida B; Fernandez-Penas P; Flowers RH; Frew JW; Gebauer KA; Giamarellos-Bourboulis EJ; Goldfarb N; Horváth B; Hsiao JL; Jemec G; Lowes MA; Marzano AV; Matusiak L; Micheletti RG; Oon HH; Orenstein LAV; Ortega-Loayza AG; Paek SY; Pascual JC; Piguet V; Resnik BI; Rosmarin D; Roth GM; Sayed CJ; Silva DLF; Thorlacius L; Tzellos T; Van der Zee H; Van Straalen K; Ingram JR, 2026, 'Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach', JAMA Dermatology, 162, pp. 72 - 79, http://dx.doi.org/10.1001/jamadermatol.2025.4652

Pham J; Sholji T; Aghajani M; Kok C; Frew JW, 2026, 'Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa', JAMA Dermatology, http://dx.doi.org/10.1001/jamadermatol.2026.2633

Kern JS; Thomsen SF; Kokolakis G; Podda M; Jemec GBE; Gebauer K; Zachariae C; Frew J; Fernandez-Peñas P; Bechara FG; Beissert S; Malandkar S; Scalzo-Inguanti K; Nandy P; Sukumar S, 2026, 'Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70594

Pham JP; Frew JW, 2026, 'Unraveling the association between acne vulgaris and inflammatory bowel disease through cross-trait genetics: From pleiotropic signals to causal biology', Journal of Investigative Dermatology, http://dx.doi.org/10.1016/j.jid.2026.06.1273

Soung J; Magnolo N; Frew J; Constanzo A; Moore AY; Xie J; Kaplan B; Stakias V; Espaillat R; Patel M; Warren RB, 2026, '73341 Effect of Risankizumab Versus Deucravacitinib on Psoriasis-Related Symptoms and Quality of Life in Patients With Moderate Plaque Psoriasis: Results From the IMMpactful Trial at Week 16', Journal of the American Academy of Dermatology, 95, pp. ab175, http://dx.doi.org/10.1016/j.jaad.2026.04.718

Sayed CJ; Martorell A; Porter ML; Bechara FG; Lev-Tov H; van der Zee HH; Hsiao JL; Frew JW; Alhusayen R; Zouboulis CC; Dessau SK; Santos LL, 2026, '75195 Povorcitinib for Moderate-to-Severe Hidradenitis Suppurativa: Week 24 Interim Phase 3 Results in Anti-TNF-Experienced Patients', Journal of the American Academy of Dermatology, 95, pp. ab345, http://dx.doi.org/10.1016/j.jaad.2026.04.1380

Pham J; Allan T; Guttman L; Frew JW, 2026, 'Deucravacitinib in Hidradenitis Suppurativa: An Open Label Proof of Concept Study', Journal of the American Academy of Dermatology, http://dx.doi.org/10.1016/j.jaad.2026.09.065

Islam R; Frew J; Kok C; Gupta M, 2026, 'New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection-An Online Survey', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 67, pp. 109 - 113, http://dx.doi.org/10.1111/ajd.70027

Sholji T; Haigh C; Islam R; Kok C; Frew JW, 2026, 'Phenotype-specific response signals following IL-23 inhibition in hidradenitis suppurativa: pooled individual patient data secondary analysis of two phase II randomized trials', Journal of the American Academy of Dermatology, http://dx.doi.org/10.1016/j.jaad.2026.08.081

Tseng H; Frew JW; Murrell DF, 2026, 'Rituximab for autoimmune blistering diseases in pregnancy and children: a clinical review', International Journal of Women's Dermatology, 12, pp. e270, http://dx.doi.org/10.1097/jw9.0000000000000270

Ingram JR; Fujita H; Gottlieb AB; Lev-Tov H; Prens E; Sayed CJ; Shi VY; Szepietowski JC; Takahashi K; Frew JW; Lambert J; Davis L; Oh T; Rolleri R; Saintmard MH; Orenstein LAV, 2025, 'Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical Trials', Pain and Therapy, 14, pp. 1861 - 1878, http://dx.doi.org/10.1007/s40122-025-00779-7

Aghajani M; Frew JW, 2025, 'New Findings in Hidradenitis Suppurativa Pathophysiology: Focus on B Cells, BAFF, BTK, and SYK', Current Dermatology Reports, 14, http://dx.doi.org/10.1007/s13671-025-00487-7

Stewart TJ; Farrell JA; Frew JW, 2025, 'Psychological Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-Analysis', Australasian Journal of Dermatology, 66, pp. e490 - e500, http://dx.doi.org/10.1111/ajd.14613

Pham J; Sholji T; Islam R; Burrell K; Kok C; Frew JW, 2025, 'Sequencing of Biologic Therapy in Hidradenitis Suppurativa: A Real-World Analysis of Treatment in Over 15,000 Patients', JEADV Clinical Practice, 4, pp. 1127 - 1129, http://dx.doi.org/10.1002/jvc2.70083

Pham J; Flora A; Kozera EK; Medianfar CE; Bouazzi D; Christensen R; Jemec GBE; Frew JW, 2025, 'Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia', Dermatology, 241, pp. 14 - 18, http://dx.doi.org/10.1159/000540455

Magnolo N; Soung J; Frew J; Costanzo A; Llamas-Velasco M; Bukhalo M; Sivamani R; Moore A; Wu T; Xie J; Patel M; Ashley D; Kaplan B; Stakias V; Espaillat R; Warren RB, 2025, 'A Phase 4 Multicenter, Randomized, Open-Label, Efficacy Assessor-Blinded Study of Risankizumab Compared With Deucravacitinib for the Treatment of Adult Patients With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy: 16-Week Results From IMMpactful', SKIN The Journal of Cutaneous Medicine, 9, pp. s631, http://dx.doi.org/10.25251/h9van576

Smith A; Frew J, 2025, 'Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance', Australasian Journal of Dermatology, 66, pp. 439 - 440, http://dx.doi.org/10.1111/ajd.14587

Bouazzi D; Nielsen SM; Hagan PG; Botvid S; Hove LS; Prens EP; Christensen R; Jemec GBE; Knecht-Gurwin K; Szepietowski JC; Anaba EL; Chehad AS; Zobiri S; Serradj A; Bhuiyan MSI; Noor T; Guillem P; Parvizi MM; Saki N; Alpsoy E; Vardar C; Kanni T; Giamarellos-Bourboulis EJ; Frew JW; Al Maharbi WHA; Van Huijstee JC; Aarts P; Dewi ST; Febriana SA; Indrastuti N; Suryawati N; Pangastuti M; Adji A; Akhyar G; Nopriyati N; Hazlianda CP; Reyes-Baraona F; Matas C; Saeed H; Moodley A; Binamer Y; Kamil MAA; Jocic I; Mijuskovic Z; Mallawaarachchi K; Gangani C; Tusheva I; Boshkovski VB; Hu D; Geng S; Medianfar CE; Saunte DML; Chandran NS; Van Der Zee HH; Zouboulis CC; Benhadou F; Villumsen B; Alavi A; Ibekwe PU; Hamzavi IH; Ingram JR; Naik HB; Garg A; Boer J, 2025, 'Prevalence of Hidradenitis Suppurativa A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies', JAMA Dermatology, 161, pp. 1022 - 1028, http://dx.doi.org/10.1001/jamadermatol.2025.2373

Byrd AS; Moreau JM; Petukhova L; Frew J, 2025, 'Differentiating the Role of Inflammation in Hidradenitis Suppurativa from that in other Inflammatory Skin Diseases', Journal of Investigative Dermatology, 145, pp. 2417 - 2427, http://dx.doi.org/10.1016/j.jid.2025.04.009

Aghajani M; Maye E; Burrell K; Kok C; Frew JW, 2025, 'Evaluating the quality and readability of online information about hidradenitis suppurativa: a systematic review', Clinical and Experimental Dermatology, 50, pp. 1937 - 1944, http://dx.doi.org/10.1093/ced/llaf236

Lam T; Gruzmark F; Ondreyka J; Lenczowski J; Harris-Tryon TA; Frew J; Lev-Tov H, 2025, 'Food as Medicine in Hidradenitis Suppurativa: A Review of Dietary Effects on Hidradenitis Suppurativa Pathogenesis', Integrative and Complementary Therapies, 31, pp. 181 - 191, http://dx.doi.org/10.1177/27683192251376656

Sholji T; Islam R; Pham J; Burrell K; Kok C; Frew JW, 2025, 'Quantifying time to medical and/or surgical therapy after diagnosis of hidradenitis suppurativa and pilonidal sinus disease: A propensity-matched real-world cohort analysis', Journal of the European Academy of Dermatology and Venereology, 39, pp. e671 - e672, http://dx.doi.org/10.1111/jdv.20494

Westerkam LL; Santiago-Soltero K; Charrow A; Frew JW; Sayed CJ, 2025, 'Safety and efficacy of biologics in patients with Down syndrome and hidradenitis suppurativa: A retrospective cohort study', Clinical and Experimental Dermatology, 50, pp. 1431 - 1433, http://dx.doi.org/10.1093/ced/llaf090

Sholji T; Islam R; Pham J; Kok C; Frew JW, 2025, 'Malignancy risk differs between hidradenitis suppurativa and pilonidal sinus disease', Journal of the American Academy of Dermatology, 92, pp. 1381 - 1382, http://dx.doi.org/10.1016/j.jaad.2025.01.076

Flora A; Pham J; Woods JA; Radzeika M; Dickson H; Malone M; Frew JW, 2025, 'The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial', Journal of Investigative Dermatology, 145, pp. 1396 - 1406.e6, http://dx.doi.org/10.1016/j.jid.2024.10.602

Johns M; Kunst H; Tng V; Frew J; Kok C; Lee S; Bonilla GM, 2025, 'Comparison of Keratinocyte Cancer Tumour and Defect Sizes Treated by Mohs Micrographic Surgery: Sydney Versus Outside Metropolitan Sydney', Australasian Journal of Dermatology, 66, pp. e148 - e154, http://dx.doi.org/10.1111/ajd.14453

Stewart TJ; Chan CWJ; Shah H; Frew J, 2025, 'Infectious complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis', International Journal of Dermatology, 64, pp. 830 - 848, http://dx.doi.org/10.1111/ijd.17527

Stewart TJ; Shah H; Frew J, 2025, 'Systematic review and meta-analysis of non-SCORTEN predictors of mortality in Stevens-Johnson syndrome and toxic epidermal necrolysis', International Journal of Dermatology, 64, pp. 849 - 860, http://dx.doi.org/10.1111/ijd.17529

Hashemi-Arend A; Lowes MA; Frew JW; Krueger J; Gierbolini A; Nayim M; Samanoglu M; Mbye PM; Shahriar F; Tobin JN; Kost RG, 2025, 'Full spectrum town halls for hidradenitis suppurativa: A model for advancing clinician-patient-researcher engagement in clinical and translational research', Journal of Clinical and Translational Science, 9, http://dx.doi.org/10.1017/cts.2025.62

Pham J; Frew JW, 2025, 'Hidradenitis Suppurativa: Pathogenesis and Inflammatory Pathways', Dermatologic Clinics, 43, pp. 179 - 191, http://dx.doi.org/10.1016/j.det.2024.12.004

Back to profile page